Cavitation Technologies, Inc.

As of March 31, 2026, Cavitation Technologies, Inc. carries a market capitalization of 7.80M, placing it among publicly traded companies globally. Its enterprise value stands at 8.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cavitation Technologies, Inc.'s next confirmed earnings release is scheduled for December 2, 2026.

As of March 31, 2026, Cavitation Technologies, Inc. has 309.72M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 681.09, and the price-to-book ratio stands at -16.71.

These figures are as of March 31, 2026. The EV/Sales ratio of 729.91 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 8.03M versus a market cap of 7.80M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Cavitation Technologies, Inc. maintains a current ratio of 0.14, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -57.60, indicating conservative leverage, while an interest coverage ratio of -84.86 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended March 31, 2026. Return on assets (ROA) is negative at -370.09, reflecting losses generated across the asset base. The company generates approximately 3,666.67 in revenue per employee across its workforce of 3.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Cavitation Technologies, Inc.'s stock has declined approximately 44.88% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.03.

Over the twelve months ended March 31, 2026, Cavitation Technologies, Inc. generated 11,000.00 in revenue and converted that into -1.19M in net income, yielding earnings per share of 0.00. EBITDA reached -1.19M, while operating income came in at -1.19M.

As of March 31, 2026, Cavitation Technologies, Inc. holds 45,000.00 in cash and equivalents against 269,000.00 in total debt, resulting in a net debt position of 224,000.00. Total book value stands at -467,000.00, with working capital of -328,000.00 providing operational flexibility.

Cavitation Technologies, Inc. produced -709,000.00 in operating cash flow over the twelve months ended March 31, 2026.

These figures cover the twelve months ended March 31, 2026. The operating margin of -10,800.00 and net profit margin of -10,800.00 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -9.46: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.13, meaning Cavitation Technologies, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Cavitation Technologies, Inc.'s most recent stock split took place on October 29, 2009 with a 1:3 split ratio.

As of March 31, 2026, Cavitation Technologies, Inc. has an Altman Z-Score of -648.50, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.